|
"yen cj"的相关文件
顯示項目 76-85 / 99 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis
|
Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Lin, CL;Wang, FT;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2013-02 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
|
Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
| 國家衛生研究院 |
2012-07-27 |
Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma
|
Yen, CJ;Lin, YJ;Yen, CS;Tsai, HW;Tsai, TF;Chang, KY;Huang, WC;Lin, PW;Chiang, CW;Chang, TT |
| 國家衛生研究院 |
2011-11-15 |
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
|
Chang, KY;Tsai, SY;Wu, CM;Yen, CJ;Chuang, BF;Chang, JY |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers
|
Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL |
| 國家衛生研究院 |
2011-07-01 |
A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery
|
Tsai, HW;Lin, YJ;Lin, PW;Wu, HC;Hsu, KH;Yen, CJ;Chan, SH;Huang, W;Su, IJ |
| 國家衛生研究院 |
2011-06-23 |
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
|
Chen, YJ;Huang, WC;Wei, YL;Hsu, SC;Yuan, P;Lin, HY;Wistuba, I;Lee, JJ;Yen, CJ;Su, WC;Chang, KY;Chang, WC;Chou, TC;Chou, CK;Tsai, CH;Hung, MC |
| 國家衛生研究院 |
2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Li, CP;Chen, JS;Chen, LT;Yen, CJ;Lee, KD;Su, WP;Lin, PC;Lu, CH;Tsai, HJ;Chao, Y |
顯示項目 76-85 / 99 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
